deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02785406

Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use

Sponsor: Peter McManus Charitable Trust

Conditions Anxiety Cocaine Use Disorder
Interventions Placebo (for suvorexant) suvorexant
Updated 14 times since 2017 Last updated: Dec 10, 2019 Started: May 31, 2016 Primary completion: Nov 15, 2018 Completion: Nov 15, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02785406, this PHASE2 trial focuses on Anxiety and Cocaine Use Disorder and remains completed. Sponsored by Peter McManus Charitable Trust, it has been updated 14 times since 2016, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Dec 2017 · 10 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Jan 2020 · 13 months · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshot~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~Dec 2022 · 9 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – present · 17 months · monthly snapshot

Change History

14 versions recorded

  1. Feb 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Feb 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

▶ Show 9 earlier versions

  1. Mar 2022 — Dec 2022 [monthly]

    Completed PHASE2

  2. Jan 2022 — Mar 2022 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jan 2022 [monthly]

    Completed PHASE2

  4. Jan 2020 — Jan 2021 [monthly]

    Completed PHASE2

  5. Dec 2018 — Jan 2020 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  6. Jun 2018 — Dec 2018 [monthly]

    Recruiting PHASE2

  7. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  8. Feb 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

  9. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Peter McManus Charitable Trust
  • The University of Texas Health Science Center, Houston
Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations